Short-term effects of combination of Satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in atients with cirrhsois without hyponatremia: a randomized, double-blind, placebo-controlled study / Ginès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F; NormoCAT study investigators: Angeli P; Angus P; Bernardi M; Bilic A; Bronowicki JP; Chira C; Dobru D; Doffoel M; Fleig W; Fraticiu A; Gadano A; Gerbes A; Gheorge L; Goldis A; Grigorescu M; Horsmans Y; Hulek P; Lata J; Lonovics J; Manns M; Masliah C; Morichaut-Beauchant M; Olteanu D; Pascu O; Planas R; Ramdani M; Ruiz del Arbol L; Siahmed SN; Stoica V; Ujszaszy L; Voiosu MR.. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - STAMPA. - 31:(2010), pp. 834-845. [10.1111/j.1365-2036.2010.04236.x]
Short-term effects of combination of Satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in atients with cirrhsois without hyponatremia: a randomized, double-blind, placebo-controlled study.
BERNARDI, MAURO;
2010
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
